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A deficient extinction of memory is particularly impor-
tant in the regime of fear, where it limits the beneficial
outcomes of treatments of anxiety disorders. Fear
extinction is thought to involve inhibitory influences
of the prefrontal cortex on the amygdala, although
the detailed synaptic mechanisms remain unknown.
Here, we report that neuropeptide S (NPS), a recently
discovered transmitter of ascending brainstem neu-
rons, evokes anxiolytic effects and facilitates extinc-
tion of conditioned fear responses when adminis-
tered into the amygdala in mice. An NPS receptor
antagonist exerts functionally opposing responses,
indicating that endogenous NPS is involved in anxiety
behavior and extinction. Cellularly, NPS increases
glutamatergic transmission to intercalated GABAer-
gic neurons in the amygdala via presynaptic NPS
receptors on connected principal neurons. These re-
sults identify mechanisms of NPS in the brain, a key
role of intercalated neurons in the amygdala for fear
extinction, and a potential pharmacological avenue
for treating anxiety disorders.
INTRODUCTION
Anxiety disorders are common diseases with a lifetime preva-
lence of up to 25% (Kessler et al., 2005). For the development
of therapeutic avenues, it is of critical importance to identify
the neural circuitries and mechanisms of neurotransmission me-
diating fear acquisition and, perhaps even more clinically impor-
tant, fear subsidence. One established experimental paradigm
to study these processes is Pavlovian fear conditioning, in which
cues paired with aversive outcomes come to elicit typical fear
responses and in which the organism learns to predict danger
in their environment (LeDoux, 2000). When conditioned cues
no longer predict danger, as can be experimentally modeled298 Neuron 59, 298–310, July 31, 2008 ª2008 Elsevier Inc.through repetitive presentations of nonreinforced cues, fear
responses decline: a behavioral phenomenon known as extinc-
tion (Maren and Quirk, 2004). Substantial evidence indicates
that extinction involves new learning that inhibits the expression
of conditioned fear rather than erases the fear memory (Maren
and Quirk, 2004; Bouton et al., 2006; Myers and Davis, 2007).
In fact, fear responses can spontaneously recover with the pas-
sage of time, be reinstated by the reinforcer alone, or be renewed
in a context-dependent manner (Maren and Quirk, 2004). This
balance between fear memory consolidation and extinction
has important clinical relevance in that it severely limits the ben-
eficial outcomes of current treatments of anxiety disorders, such
as panic and posttraumatic stress disorders. Studies in both an-
imals (Pare´ et al., 2004; Maren and Quirk, 2004) and humans
(Phelps and LeDoux, 2005) have indicated that interactions be-
tween the infralimbic region (IL) of the medial prefrontal cortex
(mPFC) and the amygdala are critically involved in the consolida-
tion of extinction learning. One intriguing possibility is that the IL
exerts an inhibitory control over signal processing in amygdaloid
circuits via GABAergic neuronal populations (Pare´ et al., 2004).
Two major populations of GABAergic neurons can be discerned
in the amygdala: ‘‘local’’ GABAergic interneurons scattered in
the local neuropil and paracapsular GABAergic intercalated
cell masses. The paracapsular intercalated cell masses are orga-
nized in two clusters: one cluster (the lateral subdivision, lpara) is
located along the external capsule, while a second cluster (the
medial subdivision, mpara) is located at the border between
the basolateral amygdaloid complex (BLA) and the central amyg-
daloid nucleus (CeA). The lpara neurons mostly enable feedfor-
ward control of signal flow from cortex to the BLA (Marowsky
et al., 2005), while the mpara neurons provide a feedforward
inhibitory gate for signals between BLA and CeA and thereby be-
tween the major input and output station of the amygdala (Royer
et al., 1999). In particular, the GABAergic intercalated cells have
been suggested to be prime candidates for mediating mPFC
influences during extinction, although the case rests on indirect
evidence only (as reviewed by Pare´ et al., 2004). While formation
of new memory represents the prevailing model of fear extinc-
tion, it does not rule out the possibility that multiple mechanisms
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erasure of conditioned fear through synaptic depotentiation
(Myers et al., 2006; Kim et al., 2007). Of the various transmitter
systems controlling synaptic interactions within the amygdala,
the implication of endocannabinoids in extinction of conditioned
fear has been well established (Marsicano et al., 2002; Lutz,
2007), although information about the neuronal targets and syn-
aptic network mechanisms mediating the fear-alleviating effects
is sparse to date.
In this respect, it is of particular interest to note that mRNA for
receptors of neuropeptide S (NPS), a recently discovered trans-
mitter with anxiolytic-like effects, displays a specific expression
pattern within the rat amygdala, with high levels occurring in and
around the intercalated cell masses (Xu et al., 2007). NPS is
a neuropeptide consisting of 20 amino acids with serine as the
amino-terminal residue (Xu et al., 2004), is highly conserved in
different vertebrate species, including humans (Reinscheid,
2007), originates from a cluster of cells in the brainstem between
the locus coeruleus and Barrington’s nucleus, and produces
robust anxiolytic effects when administered intracerebroventric-
ularly to mice in various tests of generalized anxiety (Xu et al.,
2004).
These findings prompted us to examine the mechanisms of
action of NPS in the amygdala in relation to anxious behavior,
fear acquisition, and extinction. We have combined behavioral
studies in mice and electrophysiological in vitro experiments in
amygdala slice preparations making use of GAD67-EGFP
knockin mice, a transgenic mouse strain, in which EGFP was
used as a reporter gene to tag GAD67-expressing neurons (Tam-
amaki et al., 2003). The data demonstrate that endogenous NPS
in the amygdala acts to reduce general anxiety and to facilitate
the extinction of conditioned fear responses through mecha-
nisms involving a subpopulation of intercalated GABAergic neu-
rons in the amygdala and thereby pave the way for novel phar-
macological avenues in the control of fear acquisition and
extinction.
RESULTS
Anxiolytic-like Effects of NPS in the Amygdala
The first series of experiments aimed at identifying the effects of
NPS in the amygdala on anxious behavior. NPS was locally
infused in small volumes bilaterally in the amygdala, with histo-
logically verified injection sites centered in the lateral amygdala
(LA) and basolateral (BLA) amygdaloid complex (Figure S1 avail-
able online). Anxiety was tested 20 min after termination of NPS
application via the open field and elevated plus maze test. Data
are illustrated in Figure 1. NPS-treated mice displayed a reduc-
tion in anxious behavior in both the open field test (n = 9;
Figure 1A) and the elevated plus maze (n = 7; Figure 1B) when
compared to saline-injected controls (n = 6 for each test), as
evidenced by the significant increase in visits and distances
covered in the center and the significant increase and decrease
in time spent on open and closed arms, respectively. In order to
investigate the possible involvement of endogenous NPS in anx-
iety behavior, the NPS receptor antagonist SHA 68 (Okamura
et al., 2008) was locally injected into the amygdala, using proto-
cols as for NPS. Compared to vehicle-injected controls (Cremo-phor-PBS; n = 6), SHA 68 produced a significant anxiogenic
response in mice tested in the open field (n = 6; Figure 1A).
Importantly, locomotor activity and distance covered at the bor-
der were not different between the different pharmacological
groups, and Cremophor-PBS controls did not differ in any of
the tested behaviors from saline-injected controls. In separate
groups of animals, the time course of the effect of NPS on gen-
eral anxiety was tested in the elevated plus maze. The anxiolytic
responses were significant 20 min after application of NPS (n =
7), while behavioral activity had returned to control level within
2 hr (n = 4) and 4 hr (n = 4) thereafter (Figure S3). Total locomotor
activities were not significantly different between groups at any
time. Finally, NPS-treated animals displayed anxiolytic-like
behavior in the dark-light test (Figure S4). Overall, these results
provide evidence that endogenous NPS in the amygdala, more
specifically in the LA/BLA region, induces a reduction in general
anxiety, thereby separating anxiolytic from hyperlocomotor
effects that have been observed after intracerebroventricular
injections (Xu et al., 2004).
NPS in the Amygdala Facilitates Extinction
of Conditioned Fear
The effects of NPS in the amygdala on conditioned fear and ex-
tinction were investigated next. Mice were fear conditioned in an
auditory fear conditioning paradigm, and responses to the con-
ditioned (CS+) and neutral (CS) tone were determined to assess
fear memory. The conditioned response generally took a gradu-
ated development of different behavioral components, and in
accordance with previous observations (Laxmi et al., 2003), we
considered freezing as one adequate behavioral response
indicating fear in different test situations. Twenty-four hours after
fear training, retrieval of conditioned fear was analyzed (R1), fol-
lowed by fear extinction training through successive presenta-
tion of the nonreinforced cues during five retrieval sessions
(R2–R6). Twenty-four hours later, extinction recall was tested
in two successive sessions (E1, E2), followed by renewal of con-
ditioned fear through exposure to the conditioning context (RN).
NPS was injected at different time points during the fear training
protocol in order to distinguish between effects on fear acquisi-
tion and extinction. NPS-treated animals were compared with
controls that had received saline injections at matching time
points. Freezing responses upon CS+ presentation were statis-
tically analyzed using the Mann-Whitney U test for single test
session (R1–R6, E1, E2, RN, compared to saline controls) and
the Wilcoxon test for within-group differences between the test
sessions. Data are illustrated in Figure 2. Saline controls (n = 15,
in two different groups) displayed a high level of conditioned
freezing responses upon CS+ presentation during the first
retrieval session (R1) and a continuous decline during nonrein-
forced CS+ exposure during subsequent retrieval sessions
(R2–R6), indicating fear extinction (Figures 2A and 2B, dashed
line). Differences to R1 (Wilcoxon test) became significant at
R4 in the different groups and persisted throughout extinction
training (p < 0.05). Consolidation of extinction was observed dur-
ing recall 24 hr later (E1, E2) (p < 0.05), and re-exposure to the
conditioning context resulted in a significant increase in freezing
responses to CS+ compared to E2 (p < 0.05), indicating renewal
of fear memory (RN). Next, fear training was performed 20 minNeuron 59, 298–310, July 31, 2008 ª2008 Elsevier Inc. 299
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Neuropeptide S-Mediated Control of FearFigure 1. Effects of NPS in the LA/BLA on Generalized Anxiety Behavior in the Open Field and Elevated Plus Maze
(A) Representative examples of locomotor paths, diagrams of averaged visits of the central zone, time spent in center, distances in the center and in the border
field, and total locomotor activity of NPS-, SHA 68-, and saline-treated mice in open field. (B) Representative examples of locomotor paths (open arms in vertical
direction), and averaged entries into open/closed arms and time spent on open/closed arms of NPS- and saline-treated mice in an elevated plus maze. Note the
significantly increased number of visits of the central zone, time spent in center and distance in center (A) and of entries into opens arms and time spent on open
arms (B) of NPS-treated mice compared to saline controls, while locomotor activity was similar in both groups and in both behavioral tests (data not shown for
EPM-test). SHA 68-treated mice showed significantly reduced (anxiogenic-like) responses in the open field. Behavioral data were obtained 20 min after bilateral
injection of NPS (0.5 ml, 10 mM), SHA 68 (0.5 ml, 10 mM), NaCl and Cremophor-PBS buffer, respectively. Values are mean ± SEM; * and **, significantly different from
the control group (p < 0.05 and p < 0.01, respectively).after local infusion of NPS bilaterally into the LA/BLA, at times co-
inciding with anxiolytic-like effects of the drug. Conditioned fear
responses, fear extinction, extinction recall, and renewal of fear
memory were undistinguishable from those observed in saline-
injected control animals (n = 6 each group; Figure 2A). A similar
lack of effect of NPS was observed upon application 1 hr after
training during a period of fear memory consolidation (n = 3;
data not shown). When NPS was injected 2 hr before fear
memory retrieval (Figure 2B, n = 7), animals displayed unaltered
freezing responses to CS+ presentations during the first retrieval
session (R1) but an acceleration of fear extinction compared to
controls (n = 6) upon presentation of the nonreinforced cues
during subsequent retrieval sessions with significantly reduced
freezing at R3 (p < 0.05). Application of NPS 20 min prior to R1
resulted in a significant reduction in freezing responses at R1
(p < 0.05), R2 (p < 0.05), R3 (p < 0.01), and the acute anxio-
lytic-like action could not be discerned from effects on fear ex-
tinction (n = 6; data not shown). A facilitatory effect of NPS on
fear extinction became evident during extinction recall, where
NPS-treated animals displayed significantly reduced freezing
responses compared to saline-treated controls (E1 and E2;
p < 0.05), while re-exposure to the conditioning context resulted
in a renewed fear response with no differences between groups300 Neuron 59, 298–310, July 31, 2008 ª2008 Elsevier Inc.of animals. Finally, application of NPS after extinction training
(20 min post R6; n = 5, data not shown) had no significant effect
on extinction recall nor renewal of conditioned fear responses.
Freezing in response to CS presentation was at a low level at
the various retrieval sessions in all groups (see Laxmi et al.,
2003), and a significant effect of NPS was not observed.
In order to investigate the possible involvement of endoge-
nous NPS in the amygdala in conditioned fear responses, we lo-
cally injected the NPS receptor antagonist SHA 68 (Okamura
et al., 2008) into the LA/BLA region at times that had been proven
relevant with respect to NPS action. Upon injection of SHA 68 at
2 hr before fear memory retrieval (Figure 2B, filled circles, n = 7),
animals displayed high freezing responses to CS+ presentations
throughout extinction training, with significant differences com-
pared to vehicle-injected controls from R4 to E2 (Mann-Whitney
U test; p < 0.05). Mice injected with the solvent Cremophor-PBS
at 2 hr before R1 (n = 3) showed undistinguishable freezing
responses from those in saline-injected controls (data not
shown). Noteworthy, conditioned fear behavior and extinction
were undistinguishable in the three saline-injected groups at
the three different time points (20 min prior to fear training,
20 min and 2 hr prior to R1; n = 20 total) and the Cremophor-
PBS-injected controls (n = 3). Behavioral experiments in the
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Neuropeptide S-Mediated Control of FearFigure 2. Effects of NPS in the LA/BLA dur-
ing Retrieval and Extinction of Conditioned
Fear
Averages of relative freezing duration upon CS+
presentation during retrieval sessions (R1-R6),
extinction (E1, E1), and renewal (RN). Diagrams
represent effect of bilateral injections into LA/
BLA of (A) NPS and NaCl 20 min before training,
and (B) NPS, SHA 68 and NaCl two hours before
retrieval session 1. Data are mean ± SEM. Aster-
isks indicate differences in freezing in a respective
session after administration of NPS or SHA 68
compared to saline (*, p < 0.05; **, p < 0.01).different pharmacological groups were performed largely in par-
allel and included mates of the same litters, thereby minimizing
the impact of uncontrolled variables.
NPS Enhances Synaptic Transmission at Glutamatergic
Synapses on Paracapsular GABAergic Cells
The next series of experiments aimed at identifying the mecha-
nisms of action of NPS in the synaptic network of the LA/BLA
complex and paracapsular GABAergic intercalated cells, based
upon our behavioral data and the high expression level of NPS
receptors in that area of the amygdala (Xu et al., 2007). In slice
preparations of the amygdala from GAD67-EGFP mice (Tama-
maki et al., 2003), whole-cell recordings were obtained from
LA principal neurons (LA PN) and paracapsular GABAergic inter-
calated cells (para IN). The paracapsular GABAergic intercalated
cells were readily discernible in coronal slices as clusters of
densely packed EGFP-labeled cells located at the lateral border
of the LA along the external capsule (lateral cluster, lpara) and at
medial sites facing the CeA (medial cluster, mpara; Figure S5).
Furthermore, scattered EGFP-labeled neurons were present
within the LA, most likely representing local GABAergic interneu-
rons (LA IN; Figure S5). The different neuronal cell types were
separated by their electrophysiological properties in current-
clamp recordings (Figure S5).
Next, glutamatergic synaptic transmission was evoked in
mpara IN by extracellular stimulation within the LA in the pres-
ence of 100 mM picrotoxin and 50 mM AP5. Bath application of
NPS (10 mM) resulted in an enhancement of glutamate recep-
tor-mediated EPSCs, as illustrated by the representative traces
in Figure 3A. The mean amplitudes of EPSCs in para IN were sig-
nificantly increased from30 ± 4 pA to74 ± 14 pA (n = 13) after
NPS application (Figure 3B; n = 13; p < 0.01) in slices obtained
from mice at postnatal ages P15–26. In slices from mice of the
same developmental state (P47–56) as in behavioral testing,
NPS application similarly increased the mean amplitudes of
evoked EPSCs in mpara IN from43 ± 8 pA to96 ± 19 pA (Fig-
ure 3B; n = 12; p < 0.01). The effect of NPS was near maximal at
concentrations 10–50 mM (Figure S6). Previous addition of the
NPS receptor antagonist SHA 68 (100 mM; Okamura et al.,
2008) abolished responses to NPS in all tested neurons (n = 5;
Figure 3A). Plotting the averaged amplitudes, normalized to the
mean amplitude of the EPSCs during baseline stimulation,
against time demonstrated a gradual increase of the postsynap-
tic responses after NPS application (Figure 3A). On average, the
maximal change of EPSC amplitudes in the presence of NPSwas 262% ± 62% and 220% ± 21% at P15–26 and P47–56, re-
spectively. The membrane input resistance was not significantly
altered by NPS (477 ± 30 MU at baseline, 502 ± 25 MU in NPS,
n = 26, p > 0.5; data not shown). The EPSC amplitudes stayed
constant during control stimulation (32 ± 7 pA at baseline and
32 ± 3 pA at the end of the experiment; change 100% ± 5%
of baseline; n = 3, P15–26; 50 ± 7 pA at baseline and 44 ±
6 pA at the end of the experiment; 82% ± 7%; n = 6, P47–56)
and in the presence of the NPS receptor antagonist SHA 68
(29 ± 7 pA at baseline and 30 ± 1 pA after NPS application;
change 108% ± 5%; n = 5; P15–26). The EPSCs were maximally
increased within 20–40 min after application of NPS and upon
washout returned to near-control values within 70–80 min
(Figure 3C; n = 12; P47–56). Mean amplitudes were significantly
increased by NPS application from 43 ± 8 pA at baseline to
96 ± 19 pA during maximal NPS action and gradually declined
to 68 ± 9 pA during washout (Figure 3D). The relative change
of the EPSC amplitudes was significantly reduced after washout
(144% ± 11%, n = 9) compared to the maximal change (220%
± 21%, n = 12; p < 0.05). Furthermore, in the same types of mpara
IN, GABAA receptor-mediated IPSCs were recorded in the pres-
ence of DNQX and AP5, and the effects of NPS were tested
(Figure S6). Plotting the normalized amplitudes of the IPSCs re-
vealed no change in responses after NPS application compared
to baseline stimulation. The mean amplitudes did not differ signif-
icantly (56 ± 6 pA during baseline stimulation and 62 ± 8 pA
after NPS; n = 5; Figure S6). In addition, the effects of NPS on
paired-pulse facilitation were examined. Paired-pulse facilitation
refers to an increase in a second synaptic response in a double-
stimulation protocol, relating to a presynaptically mediated in-
crease in transmitter release. EPSCs in mpara IN were recorded
upon intra LA stimulation with a paired-pulse interval of 100 ms
in slices from P47–56 mice. EPSCs showed robust paired-pulse
facilitation of 1.4 ± 0.1 (52 ± 7 pA for the first response and
63 ± 5 pA for the second response; n = 11; Figures 3E and
3F). Application of 10 mM NPS significantly (p < 0.05) reduced
the paired-pulse ratio to 0.89 ± 0.1 (124 ± 25 pA for the first re-
sponse and 102 ± 21 pA for the second response; n = 11; Fig-
ures 3E and 3F). During presence of NPS, the EPSC amplitude
of the first response was significantly increased compared to
baseline stimulation (p < 0.05). Finally, intrinsic electrotonic or
electrogenic properties of LA PN were not different before or in
the presence of NPS (Supplemental Data).
Effects of NPS on glutamatergic synaptic responses in the
other major types of neurons in this region of the amygdala,Neuron 59, 298–310, July 31, 2008 ª2008 Elsevier Inc. 301
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Neuropeptide S-Mediated Control of FearFigure 3. Target-Specific Effect of NPS on Evoked EPSCs
(A) Representative current traces of glutamate receptor-mediated EPSCs in mpara IN (in P15-26 animals, n = 13) show an increase in EPSC amplitude in the
presence of NPS at 10 mM (b, gray) compared to baseline stimulation (a, black), which is blocked by the NPS receptor antagonist SHA 68 (100 mM). Example
traces refer to the time-points (a, b) depicted in the normalized amplitude-plot. At times of near-maximal NPS action, the mean EPSC amplitudes are significantly
increased compared to pre-application baseline (B; p < 0.01), whereas amplitudes remain unchanged with no added NPS or in the presence of both NPS and
receptor antagonist (see text for further details). (C) Representative current traces of glutamate receptor-mediated EPSCs in mpara IN (in P47-56 animals, n = 12)
and normalized amplitudes during baseline stimulation (a), maximal NPS effect (b) and 70 min after NPS application (c, wash-out) show a time-dependent de-
cline of the NPS induced effects on evoked EPSCs. (D) Changes of the mean amplitudes compared to baseline amplitudes during full NPS effect (NPS versus
baseline p < 0.01) and after 70 min of wash-out (wash-out versus baseline p < 0.05). Comparison of the relative increase of EPSC-amplitudes at time points
b and c revealed a significant reduction after wash-out (F; p < 0.05). (E) Effects of NPS on paired-pulse facilitation of EPSCs evoked upon intra LA stimulation
in mpara IN. Representative current traces of paired-pulse experiments with a paired-pulse interval of 100 ms before (black) and during presence of 10 mM
NPS (gray). During NPS, only the first response increased significantly (p < 0.05), and the paired pulse ratio was significantly reduced (p < 0.05; F). Data are
mean ± SEM.principal neurons (LA PN) and local interneurons (LA IN), were
investigated next. The stimulation protocol and placement of
the stimulation electrodes were as described before. Neither
for LA PN nor for LA IN could an NPS-induced increase of EPSCs
be detected, as illustrated by representative current traces and
plots of normalized amplitudes (Figures 4A and 4B). The EPSC
amplitudes were not significantly different before or in the pres-
ence of NPS compared to baseline values (60 ± 10 pA during
baseline stimulation and 72 ± 12 pA after NPS application,
n = 6 for LA PN; 66 ± 18 pA during baseline stimulation and
89 ± 31 pA after NPS application, n = 8 for LA IN; Figures 4C
and 4D). The relative changes of the EPSC amplitudes in LA PN302 Neuron 59, 298–310, July 31, 2008 ª2008 Elsevier Inc.were 113% ± 8% and in LA IN 128% ± 13% (n = 6 and n = 8,
respectively; Figure 4E). The observed changes in LA PN and
LA IN were significantly smaller than those detected in mpara
IN (p < 0.01).
These data suggest that NPS positively modulates transmis-
sion at glutamatergic but not at GABAergic synapses on mpara
IN. Furthermore, glutamatergic synapses projecting on principal
neurons or local interneurons within the LA seem to be unaf-
fected. One caveat of the electrical stimulation is that polysynap-
tic components might contaminate glutamatergic EPSCs in the
different types of neurons. Polysynaptic responses were partic-
ularly evident in lpara IN, which led us to exclude these types of
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perimental line, stimulation strength was reduced to evoke puta-
tive monosynaptic responses in the major types of neurons and
investigate the effects of NPS. Stimulation electrodes were posi-
tioned within the LA for recording EPSCs in LA IN and in the ex-
ternal capsule for recording EPSCs in lpara IN; in view of the syn-
aptic input to mpara IN from both cortical fibers and LA/BLA,
stimulation electrodes were positioned in the external capsule
and the LA neuropil in two series of experiments (Szinyei et al.,
2000; Marowsky et al., 2005; Geracitano et al., 2007). The mono-
synaptic nature of evoked responses were indicated by high fail-
ure rates (55% ± 4%, n = 18; 13% ± 7%, n = 5; 23% ± 4%, n =
13; for mpara IN, LA IN and lpara IN, respectively; and 22% ±
5%, n = 7 for mpara IN during EC-stimulation, see Figure 5), con-
stant latencies (3.5 ± 0.2 ms, n = 18; 3.7 ± 0.2 ms, n = 5; 4.2 ± 0.3 ms,
n = 13; for mpara IN, LA IN and lpara IN, respectively; and 4.6 ±
0.5 ms, n = 7; for mpara IN during EC stimulation), and typical rise
times (10%–90%) (0.9 ± 0.1 ms, n = 10; 0.9 ± 0.2 ms, n = 5; and
1.0 ± 0.1 ms, n = 18; for lpara IN, LA IN and mpara IN,
respectively; and 1.1 ± 0.3 ms, n = 7; for mpara IN during EC
stimulation). Therefore, the EPSCs are referred to as monosyn-
aptic in the following. In mpara IN, NPS modulated monosynap-
tic EPSCs evoked upon stimulation of the local LA neuropil but
left cortically evoked EPSCs unaltered. During presence of
NPS, EPSC-success amplitudes upon stimulation of the local
LA neuropil showed only a slight, not significant increase (16 ±
2 pA during baseline stimulation and20 ± 2 pA after NPS appli-
cation, n = 18; Figure 5A). In the same neurons, NPS reduced the
failure rates significantly (25% ± 5%) compared to baseline
(control: 55% ± 4%, n = 18; p < 0.01; Figure 5A). By contrast,
monosynaptic EPSCs upon stimulation of the external capsule
Figure 4. Lack of NPS Modulatory Influence in LA PN and
LA IN
Principal neurons (A) and local interneurons (B) within the LA dis-
play no NPS-induced increase of EPSC amplitudes as shown by
representative current traces and normalized amplitude-plot. (C,
D and E) EPSC amplitudes are not significantly increased in pres-
ence of NPS compared to baseline-stimulation in LA PN (n = 6) or
LA IN (n = 8). Data are mean ± SEM.
in mpara IN (n = 7; Figure 5D) were not changed after
addition of NPS in terms of amplitude (17 ± 4 pA
versus14 ± 2 pA) and failure rates (22% ± 5% versus
28% ± 8%). Furthermore, NPS was not found to
modify properties of monosynaptic EPSCs in LA IN
or lpara IN. In LA IN (Figure 5B), neither EPSC-success
amplitudes (26 ± 10 pA and 28 ± 8 pA for baseline
stimulation and during NPS, respectively; n = 5) nor
failure rates (13% ± 7% and 10% ± 6%) changed sig-
nificantly. In lpara IN (Figure 5C), amplitudes of EPSCs
amounted to 24 ± 3 pA during baseline stimulation
and nonsignificantly increased to 33 ± 5 pA after
NPS application (n = 13). Failure rates remained unal-
tered in the presence of NPS compared to baseline
(23% ± 4% and 195 ± 3%, respectively; n = 13). These
data confirmed the specific effect of NPS on glutama-
tergic synaptic transmission to mpara IN within the
amygdala. Furthermore, the reduction in failure rate hinted at
a presynaptic location of the mediating receptors.
NPS Modulates Glutamatergic Transmission to
Paracapsular GABAergic Neurons through Receptors
Located in Presynaptic Principal Neurons
In order to distinguish between pre- and postsynaptic mecha-
nisms underlying the observed NPS-mediated increase in gluta-
matergic EPSCs, spontaneous miniature EPSCs (mEPSCs) were
recorded in mpara IN, LA PN, and lpara IN in the presence of
TTX. Results are illustrated in Figure 6. Analyses of the recorded
mEPSCs revealed no significant changes of mEPSC amplitudes
after NPS application compared to control traces in mpara IN
(19 ± 1 pA in baseline recordings and 18 ± 1 pA after NPS;
data averaged from observations in n = 18 cells), LA PN (18 ±
1 pA in baseline recordings and 18 ± 1 pA after NPS, n = 18),
and lpara IN (21 ± 1 pA in baseline recordings and 19 ± 0.8
pA after NPS, n = 14) (Figures 6A and 6B). By comparison, the
frequency of mEPSCs in mpara IN increased upon NPS applica-
tion from 1.4 ± 0.3 Hz during baseline recordings to 2.6 ± 0.6 Hz
after NPS (n = 18; Figure 6C). In LA PN and lpara IN, mEPSCs
were not significantly different before or during NPS action (for
LA IN 1.2 ± 0.4 Hz baseline, 1.3 ± 0.5 Hz after NPS; n = 18; for
lpara IN 2.9 ± 1 Hz baseline and 2.9 ± 1 Hz NPS, n = 14; Fig-
ure 6C). Because of variations in frequencies between individual
recordings, the relative increase of mEPSC frequencies was
calculated (Figure 6D). NPS significantly increased mEPSC fre-
quencies in mpara IN to 170% ± 13% of baseline frequencies
(p < 0.01) compared to unaltered frequencies in LA PN (117%
± 12%) and lpara IN (99% ± 3%). Furthermore, high-pressure so-
matic application of 200 mM glutamate in ACSF (in the presenceNeuron 59, 298–310, July 31, 2008 ª2008 Elsevier Inc. 303
Neuron
Neuropeptide S-Mediated Control of Fearof 100 mM picrotoxin, 50 mM AP5, and 1 mM TTX) to mpara IN
evoked robust excitatory responses (153 ± 32 pA; n = 12),
which showed no significant change after NPS application
(176 ± 51 pA, n = 12; 118% ± 16% of baseline; Figure S6) com-
pared to controls. Similar results were obtained in LA PN, in
which responses to exogenous glutamate were not modulated
through NPS (107 ± 17 pA to 115 ± 24 pA; 119% ± 24% of
baseline; n = 10, Figure S6). These findings support the notion
that NPS acts via a mechanism that resides on glutamatergic
terminals presynaptic to mpara IN.
Determination of the exact cellular location of the mediating re-
ceptors is hampered by the lack of specific antibodies against the
NPS receptor. High densities of neurons expressing NPSR
mRNA were observed in the LA and BLA subdivisions of the
amygdala, while only scattered signals were found in medial, ba-
somedial, and anterior cortical amygdaloid nuclei (Figures 7A and
7B). Notably and in contrast to the rat brain, no expression of
NPSR was detected in intercalated amygdaloid nuclei of the
mouse. In order to obtain more detailed information on NPSR
expression sites in amygdaloid neurons, we used two alternative
approaches. In one, NPSR mRNA was detected in single neu-
rons, which had been classified as mpara IN, lpara IN, or LA PN
based upon morphological and electrophysiological criteria,
Figure 5. NPS Reduces Failure Rates of
Glutamatergic Transmission to mpara IN
(A) Failures and amplitudes of putative monosyn-
aptic responses in mpapra IN upon intra LA-stim-
ulation before and after NPS application (NPS was
added after 50 baseline-stimulation pulses). Note
unaltered success-amplitude and reduction in
failure-rate in the example current traces (base-
line: black; NPS: gray; arrow denotes application
of NPS) and quantified mean amplitude and fail-
ure-rates (p < 0.01; n = 18; recordings pooled
from mpara IN at P 15-26 and P47-56). (B) EPSC
success-amplitudes in LA IN during intra LA-stim-
ulation stayed constant after NPS application.
NPS also left failure-rates in LA IN unaffected
(n = 5). Recordings of monosynaptic EPSCs in lpara
(C, n = 13) or mpara IN (D, n = 7) during stimulation
of the external capsule revealed no significant
alterations in EPSC success-amplitude or failure-
rates upon NPS application. Data are mean ± SEM.
through relative quantitative real-time
RT-PCR. The cytoplasm of single lpara
IN (n = 41), mpara IN (n = 21), and LA PN
(n = 45) was collected individually and
subsequently pooled according to cell
type (lpara IN, n = 20 + 21; mpara IN, n =
21; LA PN, n = 12 + 16 + 17). The cDNA
of each pool was preamplified, and sub-
sequent RT-PCR detected the reference
gene hypoxanthine-guanine phosphori-
bosyltransferase (Hprt1) in all cell types.
By contrast, the NPS receptor transcript
(Npsr1) was only detected in LA PN
(2DC(t) = 0.259 ± 0.143) with no detect-
able signal in lpara IN or mpara IN (Figure 7C). Results presented
thus far allow for a working hypothesis that NPS receptors are
expressed in LA PN, activation of which results in an increase in
glutamatergic synaptic transmission to mpara IN. The GABAergic
neurons of the mpara cell masses have been found to project to
the CeA (Pare´ and Smith, 1993) and to be contacted by axon col-
laterals of principal neurons in LA/BLA, thereby gating impulse
traffic from cortical inputs via LA/BLA to the principal output
neurons in the CeA (Royer et al., 1999; Pare´ et al., 2003). If NPS
receptors are located at glutamatergic connections from LA PN
to mpara, and activation of these receptors induces an increase
in glutamatergic excitation, it can be expected that NPS leads
to an increase in both monosynaptic excitatory responses in
mpara and disynaptic inhibitory responses in CeA principal neu-
rons (PN), while monosynaptic responses in CeA should not or to
a lesser degree be modulated (Figure 8A). In a further attempt to
identify the anatomical site of NPS receptor modulation within
this circuit, we experimentally tested this hypothesis. Whole-
cell recordings were performed at a holding potential of 50 mV
in principal neurones of the CeA next to the medial paracapsular
intercalated GABAergic clusters. Local stimulation within the LA
gave rise to biphasic postsynaptic responses (monosynaptic
EPSCs inwardly directed, and disynaptic IPSCs outwardly304 Neuron 59, 298–310, July 31, 2008 ª2008 Elsevier Inc.
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(A) Example traces of mEPSCs recorded in mpara IN (i), LA PN (ii), and lpara IN (iii) during baseline conditions (upper traces) and in the presence of NPS (lower
traces). (B) mEPSC-amplitudes are not changed by the application of NPS in mpara IN (n = 18), LA PN (n = 18), or lpara IN (n = 14). (C) While the mean mEPSC-
frequencies in LA PN and lpara IN stayed constant, the mean mEPSC-frequency in mpara IN is increased in presence of NPS. (D) The relative increase of mEPSC-
frequencies in mpara IN in the presence of NPS compared to LA PN and lpara IN is significant (p < 0.01). Data are mean ± SEM.directed) in CeA PN (Figure 8B). Both current components of the
biphasic response could be blocked by the addition of DNQX (n =
4), verifying the disynaptic nature of the IPSC (Figure 8C). EPSC
and IPSC amplitudes were monitored during 120 stimulation
pulses (interstimulus interval 20 s) and were normalized to the first
20 baseline responses. Bath application of NPS significantly in-
creased the amplitudes of the inhibitory response component,
shifting the mean amplitudes from 35 ± 6 pA during baseline stim-
ulation to 94 ± 15 pA (p < 0.01; n = 17; P15–26) during near-max-
imal action of NPS, whereas the monosynaptic EPSC component
was only slightly reduced from52 ± 12 pA to42 ± 13 pA in the
same neurons (Figure 8D). The presence of NPS significantly in-
creased the IPSC amplitudes to 282% ± 62% (p < 0.01), whereas
EPSC amplitudes were not affected (80% ± 8% of control values;
Figure 8E). Effects of NPS in neurons at P15–26 were not different
from those at P47–56 (Figures 8D and 8E), in that the mean IPSC
amplitudes were significantly increased from 35 ± 5 pA during
baseline stimulation to 71 ± 13 pA (relative change of 209% ±
25%; n = 7; P47–56) after NPS application, whereas the mean
amplitudes of the EPSCs was unaffected (93 ± 30 pA baseline
and 98 ± 28 pA NPS; 122% ± 15%; n = 7; Figures 8D and 8E).
DISCUSSION
The present study aimed at identifying the mechanisms of action
of NPS in neuronal circuits of the mouse amygdala in relation to
anxious behavior, conditioned fear, and fear extinction. Three
main findings were obtained. First, local injection of NPS into
the basolateral amygdaloid complex resulted in an anxiolytic-
like effect, reflected by an acute reduction in general anxiety
and an accelerated extinction of conditioned fear, while injection
of the NPS receptor antagonist SHA 68 exerted functionally op-
posing effects. Second, NPS increased glutamatergic synaptictransmission to intercalated GABAergic neurons of the medial
paracapsular cluster through a presynaptic effect mostly involv-
ing principal neurons in the LA. Third, NPS receptors were shown
to be densely expressed in the mouse BLA complex and, at the
single-cell level, in LA principal neurons but not paracapsular
GABAergic neurons. The following discussion examines the
possibility that these effects are functionally interrelated.
Sites of NPS Modulation in Neuronal
Circuits of the Amygdala
By virtue of their location, paracapsular intercalated cells are ide-
ally suited to control signal flow in the amygdala in a feedforward
inhibitory manner. While neurons in both lpara and mpara clus-
ters share a GABAergic nature and are densely innervated by
excitatory cortical input fibers (reviewed by Pare´ et al., 2004),
they contact different major targets in the amygdaloid neuronal
network. Neurons in the lpara cluster project to the BLA complex
and generate feedforward IPSPs in BLA principal neurons
(Marowsky et al., 2005), while mpara neurons are connected to
mediate topographically organized feedforward inhibition to
principal neurons in the CeA nucleus (Royer et al., 1999). Further-
more, stimulation of the BLA complex evokes short-latency
EPSPs in mpara neurons, indicating monosynaptic input from
the respective principal neurons (Royer et al., 1999). Another
population of GABAergic neurons is represented by local inter-
neurons, comprising around 25% of the neuronal population,
which also receive excitatory cortical inputs and mediate feed-
forward (and feedback) inhibition to the principal neurons within
the local neuropil (Szinyei et al., 2000). We have shown in the
present study that stimulation of NPS receptors resulted in an
increase in glutamatergic synaptic transmission to paracapsular
intercalated neurons. The following line of evidence suggests
that synaptic connections between LA principal neurons andNeuron 59, 298–310, July 31, 2008 ª2008 Elsevier Inc. 305
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located at presynaptic sites of these connections. (1) NPS
increases the frequency, but not the amplitude, of mEPSCs in
mpara IN, but not lpara IN or principal neurons. (2) NPS de-
creases the failure rate with no effect on amplitude of putative
monosynaptic EPSCs evoked by LA stimulation in mpara IN.
(3) Putative monosynaptic EPSCs evoked in mpara IN by stimu-
lation within the LA are modulated by NPS, whereas putative
monosynaptic EPSCs evoked in the same type of neurons by
Figure 7. NPS Receptor Expression in the Amygdala
(A) In situ hybridization of a coronal mouse brain section showing strong ex-
pression of NPSR mRNA in the lateral and basolateral parts of the amygdaloid
complex. (B) Adjoining section stained with cresyl violet as a reference. Abbre-
viations: opt: optic tract; BLA: basolateral amygdaloid complex, anterior part;
BMA: basomedial amygdaloid nucleus, anterior part; MeAV: medial amygda-
loid nucleus, anteroventral part; ACo: anterior cortical amygdaloid nucleus; ic:
internal capsule; DI: dysgranular insular cortex; GI: granular insular cortex; AIP:
agranular insular cortex, posterior part; LaDL: lateral amygdaloid nucleus,
dorsolateral part; DEn: dorsal endopiriform nucleus; scale bar: 100 mm. (C) Rel-
ative quantitative real-time RT-PCR of pre-amplified cDNA prepared from
cytoplasm of single lateral (lpara IN) and medial (mpara IN) paracapsular inter-
neurons, and LA principal neurons (LA PN). Transcript levels of Npsr1 were
normalized to the reference gene Hprt1. Data are mean ± SEM. See text for
statistical details.306 Neuron 59, 298–310, July 31, 2008 ª2008 Elsevier Inc.stimulation of the external capsule are not modulated by NPS.
(4) Putative monosynaptic EPSCs evoked by stimulation of the
external capsule or within the LA in lpara IN or local IN in LA, re-
spectively, are not affected by NPS. (5) Upon paired stimulation
within the LA, NPS increases the amplitude of EPSCs in mpara IN
in response to the first stimulus and decreases the paired-pulse
ratio, indicating an NPS-mediated increase in initially low release
probability (Debanne et al., 1996). (6) Semiquantitative PCR from
single, physiologically identified types of neurons shows that
NPS receptors are expressed in LA principal neurons, but not
in mpara or lpara interneurons.
Target-specific modulation of presynaptic release has been
described in various brain regions, including glutamatergic
transmission to subsets of GABAergic neurons (Ferraguti et al.,
2005). The mechanisms underlying the target specific action of
NPS in the amygdala observed in the present study remain un-
known but may relate to various subtypes of LA/BLA principal
neurons (Sosulina et al., 2006) or synapse-specific expression
of NPSR, as has recently been reported for presynaptic NMDA
receptors in rat somatosensory cortex (Brasier and Feldman,
2008). It is important to note that different sites of stimulation
were used in the present study in order to activate the major
glutamatergic synaptic connections to the different types of
neurons of interest. This approach allows us to draw conclusions
on their involvement in NPS modulation, but does not, of course,
provide an exclusive or complete profile. For instance, microsti-
mulation within the LA may have activated cortical fibers en pas-
sant, adding to the recorded EPSCs in mpara IN. However, no
NPS receptor expression has been observed in the mouse infra-
limbic prefrontal cortex by in situ hybridization (Y.-L.X. and
R.K.R., unpublished data), thereby voting against the possibility
that the major cortical input relating to fear extinction is involved
in NPS action. Taken together, available data strongly suggest
that NPS mediates an increase in glutamatergic synaptic trans-
mission to mpara IN through NPS receptors located at presynap-
tic sites in connected principal neurons in the LA. While this
scenario is not an exclusive or complete one, it nevertheless
represents the most parsimonious interpretation of our data
from single-cell electrophysiological, RNA expression, and
anatomical experiments.
Action of NPS in Amygdaloid Circuits
in Relation to Fear Behavior
The behavioral consequences of NPS in the amygdala were in-
vestigated in the present study through bilateral application of
NPS and the NPS receptor antagonist SHA 68 aimed at the
basolateral amygdaloid complex. The exact distribution of the
drug could not be assessed under the present experimental
conditions, but the locality of the injection site in LA/BLA and
the restricted diffusion of NPS were verified through histological
reconstruction of the position of the needle injector tip and fluo-
rescently labeled Cy3-NPS, respectively. NPS, under these con-
ditions, exerted anxiolytic-like effects in three different tests of
anxiety, namely the open field, the elevated plus maze, and the
dark-light test, which were not associated with an increase in
locomotor activity and thereby differed from results obtained af-
ter intracerebroventricular application of NPS (Xu et al., 2004).
These findings support the notion that NPS affected a local
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(A) Schematic representation of synaptic interconnections from principal neurons in the LA (LA PN) via mpara IN to principal neurons in the CeA (CeA PN). In-
crease in excitatory synaptic transmission by an NPS-dependent presynaptic mechanism in LA PN should result in an increase in feedforward inhibition via mpara
IN on CeA PN. (B) Recording of biphasic (EPSC monosynaptic, IPSC disynaptic) postsynaptic currents in CeA PN at a holding-potential of50 mV during intra LA
baseline-stimulation (a, black trace) and in presence of NPS (b, gray trace). Application of NPS specifically enhanced the disynaptic inhibitory current component
(IPSC), but leaves the excitatory current component (EPSC) almost unaffected, as indicated by the normalized amplitudes. (C) The disynaptic nature of the IPSC
was verified by blocking both current components (IPSC and EPSC) with DNQX after NPS application. (D) NPS selectively increased the amplitudes of the
disynaptic IPSC in P15-26 (n = 17) and P47-56 mice (n = 7), whereas the amplitudes of the EPSCs were unaffected at both ages. (E) The relative change of
the IPSC-amplitude is highly significant (p < 0.01) compared to the EPSC-amplitude. Data are mean ± SEM.neuronal network in the present study and limit the possibility
that arousal-like effects (Xu et al., 2004) confounded the interpre-
tation of the behavioral data. The anxiolytic effects of NPS were
observed within 20 min after application, and fully declined after
2 hr, indicating an acute effect on the expression of fear. It is
important to note that a similar time course of action was also
observed with respect to arousal-like hyperlocomotion after in-
tracerebroventricular application of NPS (Xu et al., 2004) and
with respect to the increase in glutamatergic transmission to
mpara IN in vitro (present study). That endogenous NPS in the
amygdala is involved in fear behavior is indicated by the anxio-
genic-like effect obtained upon application of the NPS receptor
antagonist SHA 68.
Another series of experiments sought to determine whether
NPS is involved in the acquisition or extinction of fear memory
by delivering NPS at defined time points in relation to training
or testing in a Pavlovian fear conditioning paradigm. To distin-
guish between possible effects on acquisition and expres-
sion of fear, two groups of animals received NPS immediately
(20 min) before fear training or immediately (20 min) before testing
conditioned responses to the CS during retrieval sessions 24 hr
after training. Pretraining application of NPS had no effect on
conditioned fear responses as compared to vehicle-injected
controls, whereas pretesting application resulted in a decreasein conditioned fear responses, indicating an influence of NPS
on fear expression rather than fear learning. The finding that
NPS applied 1 hr after training yielded conditioned fear re-
sponses indistinguishable from controls is in line with these
conclusions. Furthermore, the lack of effect of NPS upon both
pre- and posttraining injections on conditioned fear responses
is suggestive of a lack of influence on fear memory consolidation.
It should be kept in mind, however, that the results in the present
study were obtained upon local injection of NPS into the BLA
complex and the use of auditory cued fear conditioning para-
digms. Additional studies involving other forms of fear memory
and extended neuronal circuits, as for instance, contextual fear
and hippocampal networks (see Maren and Quirk, 2004), are
needed to unravel additional potential sites and mechanisms
of NPS influence on conditioned fear behavior. One consistent
observation made in the present study was that application of
NPS immediately (20 min) before the first retrieval session
resulted in decreased fear responses throughout successive
retrieval trials used for extinction training. In addition, tests of
consolidated extinction performed 24 hr after extinction learning
revealed reduced fear responsiveness. To further distinguish
between effects on expression of fear versus extinction of fear,
NPS was applied 2 hr before the first retrieval session. Condi-
tioned fear responses during the first retrieval trial were notNeuron 59, 298–310, July 31, 2008 ª2008 Elsevier Inc. 307
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followed a faster time course compared to controls. Application
of the NPS receptor antagonist SHA 68 at the same time point
before retrieval had no significant effect on the expression of
the first conditioned response, but resulted in a significant
impairment of extinction learning and recall. Thus, NPS in the
amygdala engages cellular processes that facilitate fear extinc-
tion through an action in addition to that on fear expression.
How might this dual effect of NPS be mediated? One likely
route involves mobilization of intracellular Ca2+ upon activation
of NPS receptors (Reinscheid et al., 2005). NPS receptors are
located at glutamatergic synapses from LA principal neurons
to mpara IN, and receptor activation results in an increase in glu-
tamate release (as discussed above). The major projection site of
mpara IN is the CeA (Royer et al., 1999; Likhtik et al., 2005), and
the increase in glutamatergic transmission to this population of
GABAergic neurons will impose an additional inhibitory influence
on the CeA, the major output station of the amygdala for fear ex-
pression of behavior. It is interesting to note that IPSCs in the
CeA are almost exclusively carried by a2-subunit-containing
GABAA receptors (Marowsky et al., 2004). Given the importance
of a2-subunit-containing GABAA receptors in anxiolysis (Ru-
dolph et al., 2001), an NPS-mediated increase in afferent activa-
tion of these GABAergic mechanisms via the mpara IN may help
to explain the strong anxiolytic-like effect observed upon local
injection of NPS in the present study. Importantly, NPS receptors
are positively coupled to the cAMP/PKA system (Reinscheid
et al., 2005). A result of NPS receptor-activated cAMP/PKA is
phosphorylation of MAPK (Reinscheid et al., 2005), potentially
giving rise to long-term effects involving nuclear regulation of
protein synthesis. In fact, fear extinction is sensitive to modula-
tion of kinase activity in the BLA complex, including the MAPK-
ERK pathway (Lu et al., 2001; Herry et al., 2006) and requires
de novo protein synthesis in the BLA (Yang and Lu, 2005). NPS
may thus represent a transmitter system supporting a link to
these processes in principal neurons in the LA, thereby enabling
a lasting increase in efficacy of synaptic connections to GABAer-
gic mpapra IN and a modulation of fear extinction on a long-term
scale. In line with this is the previous finding that synaptic long-
term potentiation of BLA inputs to mpara IN involves presynaptic
mechanisms (Royer and Pare´, 2002). Many neurons in the LA/
BLA remain CS responsive during extinction (Repa et al., 2001)
and will mediate via NPS-potentiated transmission to mpara IN
an increased inhibitory input to the CeA, thereby facilitating
fear extinction on a long-term scale.
Collectively, our findings imply that endogenous NPS has
a dual function to acutely attenuate anxiety-like responses and
later facilitate extinction of aversive memories. Such dual effects
could be therapeutically beneficial to treat conditions like post-
traumatic stress disorder or chronic anxiety disorders.
EXPERIMENTAL PROCEDURES
All experiments were carried out in accordance with the European Commit-
tees Council Directive (86/609/EEC) and US federal regulations and guide-
lines for experimentation on animals. Protocols were approved by the
Bezirksregierung Mu¨nster (AZ 50.0835.1.0, G 53/2005) and the local Institu-
tional Animal Care and Use Committee (IACUC) of the University of California,
Irvine.308 Neuron 59, 298–310, July 31, 2008 ª2008 Elsevier Inc.Behavioral Testing In Vivo
Mice (C57BL/6J; 8–12 weeks old) were implanted with a 26 gauge stainless-
steel guide cannula bilaterally in the LA/BLA (stereotaxic coordinates:
1.8 mm anterior, 3.7 mm lateral, and 3.2 mm dorsoventral from brain surface)
under deep pentobarbital anesthesia (75 mg/kg i.p.). Animals were allowed to
recover from surgery for at least 4 days. Local drug infusion was performed
under anesthesia through forene inhalation (isofluran, 1-chloro-2,2,2-trifluor-
oethyl-difluoromethylether; induction: 2.5%, maintenance: 1.5%; in O2; flow
rate 1 l/min). Using a 10 ml Hamilton microliter syringe, the following solutions
were infused with a 33 gauge beveled needle injector (0.1 ml/min, 0.5 ml each
side): SHA 68 (10 mM, in 10% Cremophor-PBS buffer), NPS (10 mM), and, as
vehicle controls, saline, 10% Cremophor-PBS buffer. Drugs were applied (1)
at different times (20 min, 2 hr, 4 hr) before tests of general anxiety, (2) before
(20 min) or after (1 hr) fear conditioning, and (3) at different times before (20 min,
2 hr) retrieval 1 as well as immediately after retrieval 6 (Supplemental Data and
Figure S2). One individual animal underwent only one type of test of general
anxiety or underwent the fear training/retrieval protocol, only one substance
was tested in an individual animal, drug effects were compared with vehicle
controls using the same injection protocols, and the behavioral testing was
performed by the experimenter blind to pharmacological treatment of mice.
At the end of the experiments, locations of the infusion cannula were histolog-
ically verified in frozen frontal sections of 40 mm, stained with cresyl violet. Fur-
thermore in individual animals (n = 9), the diffusion of NPS solution was verified
using microinjection of Cy3-NPS (Phoenix Pharmaceuticals, Inc., Belmont,
USA) and verification of injection/diffusion sites in 30 mm coronal cryosections
under a fluorescent microscope, followed by histological verification through
cresyl violet (Figure S1). General anxiety was tested using the open field
test, plus maze test, and dark-light test (Supplemental Data). Fear conditioning
was performed using a fear training apparatus (TSE, Bad Homburg, Germany).
On day 1, animals were adapted through two presentations of six CS (2.5 kHz
tone, 85 dB, stimulus duration 10 s, interstimulus interval 20 s; intertrial interval
6 hr). On the next day, fear conditioning was performed through two exposures
of three randomly presented CS+ (10 kHz tone, 85 dB, stimulus duration 10 s,
randomized interstimulus interval 10–30 s; intertrial interval 6 hr), each of which
was coterminated with a US (scrambled foot shock of 0.4 mA, duration 1 s).
Twenty-four hours later (day 3), single animals were transferred to the retrieval
environment (novel context) and habituated over a period of 30 min, before
being exposed to six retrieval sessions (R1–R6) for extinction training (intertrial
interval 30 min), each consisting of a set of four CS and (40 s later) a set of four
CS+ (stimulus duration 10 s, interstimulus interval 20 s). After 24 hr (day 4),
recall of extinction was tested by exposing the animal to one set of 4 CS
and 40 s later to a set of 4 CS+ (stimulus duration 10 s, interstimulus interval
20 s). Extinction recall was tested twice (E1, E2; interval 30 min). For renewal
of extinct fear (RN), mice were returned to the initial shock context and re-
ceived a set of 4 CS and 40 s later a set of 4 CS+. The conditioning protocol
is illustrated in Figure S2.
Analysis of Behavioral Data
For offline evaluation of conditioned freezing behavior (immobilization except
for respiratory movements), a time line version of Wintrack was used (see
Laxmi et al., 2003). Freezing time was calculated as percentage during total
CS+ presentations within a recording session (R1 to R6, E1, E2, RN). Data
are presented as mean with standard error of the mean (±SEM). Mann-Whitney
U test or Wilcoxon test were used, as applicable.
In Situ Hybridization for NPS Receptors
A rat NPSR probe was used to hybridize coronal mouse brain sections at low
stringency. Procedures and materials were essentially as described before (Xu
et al., 2007). For the final stringent wash, sections were incubated for 30 min in
0.3 3 SSC/1 mM DTT at 60C.
Electrophysiological Recordings in Amygdala Slices In Vitro
GAD67-EGFP mice (P15–P26 or P47–P56) were anesthetized with forene (iso-
fluran, 1-chloro-2,2,2-trifluoroethyl-difluoromethylether) and killed by decapi-
tation. Coronal slices containing the amygdala were prepared and whole-cell
patch-clamp recordings were performed as described previously (Supplemen-
tal Data; Szinyei et al., 2000, 2003). Specifically, neurons were approached
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scopy (B/W-camera CF8/1, Kappa, Gleichen, Germany). EGFP-GAD67-ex-
pressing neurons were identified by fluorescent microscopy (Axioskop 2 FS
plus, Zeiss, Germany). Neurons with resting membrane potential positive to
60 mV were rejected from analysis. Extracellular stimuli (100 ms duration,
200 to 600 mA) were delivered through a bipolar stainless-steel electrode
placed in the LA or external capsule (Szinyei et al., 2000, 2003). Picrotoxin
(100 mM), CGP55845 (10 mM), and D-(-)-2-amino-5-phosphonopentanoic
acid (AP5, 50 mM) or 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 mM) and
AP5 (50 mM) were added to the bathing solution as required to isolate AMPA
or GABAA receptor-mediated current components (toxins purchased from
Tocris Cookson Ltd). NPS stock solution (NPS in phosphate-buffered saline
and 0.1% bovine serum albumin) was diluted to a concentration of 1 mM and
bath applied (final concentration of 10 mM; for dose-response see Figure S6).
The NPS receptor antagonist SHA 68 was solved in dimethyl sulfoxide
(DMSO) and was applied at a final concentration of 100 mM prior to addition
of NPS (final concentration of DMSO <0.2%). Glutamate (200 mM, Biotrend)
was locally applied in close vicinity (15–20 mm) of a recorded cell in small
volumes (10–50 pl, eight times at 5 min intervals) using pressure pulses
(Picospritzer II, General Valve Corporation, New Jersey, USA).
Analysis of In Vitro Data
Effects of NPS on postsynaptic currents (PSCs) were analyzed as follows.
After baseline stabilization, PSCs were recorded upon alternating stimulation
at 0.05 Hz. Amplitudes of evoked EPSCs were calculated and averaged
from 15 consecutive EPSCs during baseline conditions (before application
of NPS) and 15 consecutive EPSCs during near-maximal action of NPS from
original current traces in a given neuron. Obtained values were averaged
from different neurons and are presented as mean amplitude (in pA) under
baseline conditions and in the presence of NPS. Normalized mean amplitudes
were obtained from two lines of experiments. First, EPSC amplitudes obtained
during action of NPS were normalized with respect to baseline EPSCs in indi-
vidual neurons, and averaging the normalized values from different neurons
yielded NPS responses in percent baseline. Second, in a group of control cells
(without application of NPS), EPSCs were monitored over the same time
course as for NPS experiments, amplitudes at time points matching maximal
NPS action were normalized with respect to baseline EPSCs, and averaging
the normalized values from different neurons yielded control responses in per-
cent baseline. Data for washout were obtained following the same procedures,
but at time points after decline of NPS action. For analyses of putative mono-
synaptic responses, signals smaller than two times the standard deviation of
baseline noise were declared as failures and were excluded. Paired-pulse
experiments consisted of two consecutive stimuli with an interval of 100 ms.
Traces containing failures produced by at least one of the two stimuli were re-
jected from analysis. The paired-pulse ratio was calculated (Amplitude EPSC2/
Amplitude EPSC1) during baseline stimulation and in presence of NPS. Minia-
ture EPSCs were recorded over a time period of 150 s (100 traces with 1.5 s
duration at a sampling rate of 5 kHz) to determine control amplitudes and
frequencies of glutamate receptor-mediated currents. Twenty-five minutes
after NPS application, recordings of mEPSCs were repeated. Data sets were
imported to ‘‘MiniAnalysis’’ (Synaptosoft Inc., Decatur, GA, USA), and ampli-
tudes and frequencies prior and post NPS application were identified. Mean
frequencies and amplitudes of individual recordings were averaged and tested
for significance. Data are presented as means with standard error of the mean
(±SEM). For statistical comparison, ANOVA or Student’s t test were used, as
applicable.
Cell-Type-Specific Quantitative Real-Time RT-PCR
After establishing whole-cell configuration with the patched neuron, in some
cases after recording (5 min), the cell was lifted above the slice, the cell content
was sucked into the pipette and transferred into 3 ml carrier RNA buffer
(RNeasy Micro Kit, QIAGEN) by breaking the tip of the pipette and expelling
3 ml of solution with positive pressure. The pipette solution (6 ml) was supple-
mented with a recombinant ribonuclease inhibitor (0.24 U/ml; RNasin; Prom-
ega, Madison, WI, USA). Cytoplasm from single, identified cells were pooled
(lpara IN: two groups of 20 and 21 pooled cells; mpara IN: 21 pooled cells;
LA PN: three groups of pooled cells: 12, 17, 16, respectively), and the RNAwas isolated without DNase treatment (all primers designed to be intron-
spanning) using an RNA isolation kit (RNeasy Micro Kit, QIAGEN). Reverse
transcription (RT) protocol was used in cDNA preparation from isolated RNA
(Sosulina et al., 2006) and subsequently preamplified as modified from Allison
et al. (2006). A single-plex PCR (20 cycles) was performed (denaturation at
94C, 25 s; annealing at 51C, 2 min for the first five cycles, and 45 s for the
remaining cycles; extension at 72C, 60 s; final elongation at 72C, 7 min) for
hypoxanthine-guanine phosphoribosyltransferase (Hprt1, reference gene;
Chen et al., 2001) and neuropeptide S receptor 1 (Npsr1). Relative quantitative
real-time PCR was performed on preamplified cDNA using FAM-labeled
detection assays (TaqMan, Applied Biosystems) for the Npsr1 and Hprt1 in
conjunction with the Real Master Mix (5Prime) in an ABI Prism 7000 Sequence
Detection System (Applied Biosystems; 50 cycles of 15 s at 95C and 1 min at
60C preceded by a 2 min decontamination step at 50C and 10 min denatur-
ation step at 95C). Primer sequences are specified in Supplemental Data.
Transcript levels of the Npsr1 were normalized to Hprt1 using the equation
2–DC(t), where C(t) is the mean cycle threshold level and DC(t) = (C(t) Npsr1)
 (C(t) Hprt1) (Livak and Schmittgen, 2001).
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures and
figures and can be found with this article online at http://www.neuron.org/
cgi/content/full/59/2/298/DC1/.
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